Skip to main content
Kent Academic Repository

Browse by Journal

Group by: Creator's name | Item Type | Date | No Grouping
Jump to: B | G | H | M | W | Y
Number of items: 9.

B

Banerji, Udai, Dean, Emma J., PĂ©rez-Fidalgo, J. Alejandro, Batist, Gerald, Bedard, Philippe L., You, Benoit, Westin, Shannon N., Kabos, Peter, Garrett, Michelle D., Tall, Mathew, and others. (2018) A Phase 1 open-label study to identify a dosing regimen of the pan-AKT inhibitor AZD5363 for evaluation in solid tumors and in PIK3CA-mutated breast and gynecologic cancers. Clinical Cancer Research, 24 (9). pp. 2050-2059. ISSN 1078-0432. E-ISSN 1557-3265. (doi:10.1158/1078-0432.CCR-17-2260) (KAR id:63859)
Format: PDF Format: PDF

Banerji, Udai, van Doorn, Leni, Papadatos-Pastos, Dionysis, Kristeleit, Rebecca, Debnam, Phillip, Tall, Matthew, Stewart, Adam, Raynaud, Florence, Garrett, Michelle Dawn, Toal, Martin, and others. (2012) A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors. Clinical Cancer Research, 18 (9). pp. 2687-2694. ISSN 1078-0432. (doi:10.1158/1078-0432.CCR-11-3165) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:58565)

G

Gilmour, Lynn M. R., Macleod, Kenneth G., McCaig, Alison, Sewell, Jane M., Gullick, William J., Smyth, John F., Langdon, Simon P. (2002) Neuregulin expression, function, and signaling in human ovarian cancer cells. Clinical Cancer Research, 8 (12). pp. 3933-3942. ISSN 1078-0432. (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:3987)
Format: PDF

H

Hayes, Nandini V. L., Blackburn, Edith, Smart, Laura V., Boyle, Morgan M., Russell, Graham A., Frost, Teresa M., Morgan, Byron J. T., Baines, Anthony J., Gullick, William J. (2007) Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer. Clinical Cancer Research, 13 (11). pp. 3147-3155. ISSN 1078-0432. (doi:10.1158/1078-0432.CCR-06-2237) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:2203)
Format: PDF

M

Michaelis, Martin, Bliss, Jennifer, Arnold, Sonja C., Hinsch, Nora, Rothweiler, Florian, Deubzer, Hedwig, Witt, Olaf, Langer, Klaus, Doerr, Hans Wilhelm, Wels, Winfried S., and others. (2008) Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins. Clinical Cancer Research, 14 (20). pp. 6531-6537. ISSN 1078-0432. (doi:10.1158/1078-0432.CCR-08-0821) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:31386)

McLeod, Robert, Kumar, Rajiv, Papadatos-Pastos, Dionysis, Mateo, Joaquin, Brown, Jessica S., Garces, Alvaro H. Ingles, Ruddle, Ruth, Decordova, Shaun, Jueliger, Simone, Ferraldeschi, Roberta, and others. (2020) First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors. Clinical Cancer Research, . ISSN 1078-0432. (doi:10.1158/1078-0432.CCR-20-0700) (KAR id:82812)
Format: PDF

W

Walton, Mike I., Eve, Paul D., Hayes, Angela, Valenti, Melanie R., De Haven Brandon, Alexis K., Box, Gary, Hallsworth, Albert, Smith, Elizabeth L., Boxall, Kathy J., Lainchbury, Michael, and others. (2012) CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs. Clinical Cancer Research, 18 (20). pp. 5650-5661. ISSN 1078-0432. (doi:10.1158/1078-0432.CCR-12-1322) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:58558)

Y

Yap, Timothy A., Walton, Mike I., Grimshaw, Kayla M., te Poele, Robert H., Eve, Paul D., Valenti, Melanie R., De Haven Brandon, Alexis K., Martins, Vanessa, Zetterlund, Anna, Heaton, Simon P., and others. (2012) AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity. Clinical Cancer Research, 18 (14). pp. 3912-3923. ISSN 1078-0432. (doi:10.1158/1078-0432.CCR-11-3313) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:58561)

Yap, Timothy A., Yan, Li, Patnaik, Amita, Tunariu, Nina, Biondo, Andrea, Fearen, Ivy, Papadopoulos, Kyriakos P., Olmos, David, Baird, Richard, Delgado, Liliana, and others. (2014) Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers. Clinical Cancer Research, 20 (22). pp. 5672-5685. ISSN 1078-0432. E-ISSN 1557-3265. (doi:10.1158/1078-0432.CCR-14-0868) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:54928)

This list was generated on Fri May 10 23:25:12 2024 BST.